428 rows
| No. | Description of goods | Goods code | |
|---|---|---|---|
| No. | Name of the active ingredient | Form of use | Goods code |
| 1 | Finished drug product containing: Dextrose monohydrate; Sodium chloride; Sodium lactate; Potassium chloride; Calcium chloride.2H2O | Intravenous infusion solution | 3004. 90. 91 |
| 2 | Finished pharmaceutical product containing: Tinidazole; Clarithromycin; Lansoprazole | Oral form | 3004.20.31 |
| 3 | Finished pharmaceutical product containing: Glucosamine sulfate potassium chloride; Manganese Amino acid chelate; Zingiber officinale rhizome ext. | Capsule | 3004.90.99 |
| 4 | Finished pharmaceutical product containing: Diphenhydramine HCl; Ammonium Chloride; Sodium Citrate; Menthol | Syrup | 3004.90.59 |
| 5 | Finished pharmaceutical product containing: Pancreatin; Simethicone | Enteric-coated film tablet | 3004.90.99 |
| 6 | Finished drug product containing: Biodiastase 2000 I; Lipase II; Cellulase AP3 II; Simethicone | Film-coated tablet | 3004.90.99 |
| 7 | Finished pharmaceutical product containing: Tobramycin; Dexamethasone | Eye drops | 3004.20.99 |
| 8 | Finished pharmaceutical product containing: Lactobacillus acidophilus (sp. L. gasseri); Bifidobacterium infantis; Enterococcus faecium | Hard capsule | 3004.90.99 |
| 9 | Finished drug product containing: Ursodeoxycholic acid; Thiamine nitrate; Riboflavin | Soft capsule | 3004.50. 91 |
| 10 | Finished drug product containing: Cefoperazone; Sulbactam | Powder for injection | 3004.20.99 |
| 11 | Finished drug product containing: Desloratadine; Pseudoephedrine | Extended-release tablet | 3004.42.00 |
| 12 | Finished pharmaceutical product containing: Fluocinolone acetonide; Neomycin sulphate[1] | Skin cream | 3004.32.40 |
| 13 | Finished pharmaceutical product containing: Dipyridamole; Acetylsalicylic acid | Extended-release capsule | 3004.90.89 |
| 14 | Finished drug product containing Paracetamol; Phenylephrine hydrochloride; Ascorbic acid | Powder for oral use | 3004.90.51 |
| 15 | Finished pharmaceutical product containing: Rifampin; Isoniazid | Film-coated tablet | 3004.20.91 |
| 16 | Finished pharmaceutical product containing: Rifampicin; Isoniazid; Ethambutol hydrochloride | Film-coated tablet | 3004.20.91 |
| 17 | Finished pharmaceutical product containing: Telmisartan 40mg; Hydrochlorothiazide 12,5mg | Tablet | 3004.90.89 |
| 18 | Finished pharmaceutical product containing: Aluminium phosphate gel; Magnesium oxide | Suspension | 3004.90.99 |
| 19 | Finished drug product containing: Cefepime hydrochloride; Arginine | Powder for injection | 3004.20.99 |
| 20 | Finished pharmaceutical product containing: Piperacillin Sodium; Tazobactam Sodium | Powder for injection | 3004.10.19 |
| 21 | Finished drug product containing: Salts of diatrizoic acid: meglumine salt; | Injection solution | 3004.90.99 |
| 22 | Finished pharmaceutical product containing: Lopinavir; Ritonavir | All forms | 3004.90.82 |
| 23 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-Lysine acetate; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-alanine, L-Arginine; L-Aspartic acid; L-Glutamic acid; L-Histidine; L-Proline,... | Intravenous infusion solution | 3004.90.99 |
| 24 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; Lysine Hydrochloride; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-alanine; L-Arginine; L-Ornithine-L-Aspartate; L-Histidine; L-Proline; D-Sorbitol; Aminoacetic acid. | Intravenous infusion solution | 3004.90.99 |
| 25 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-Lysine Acetate; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-Alanine; L-Arginine | Intravenous infusion solution | 3004.90.99 |
| 26 | Finished drug product containing: Amlodipine; Atorvastatin | All forms | 3004.90.89 |
| 27 | Finished pharmaceutical product containing: Rabeprazole; Tinidazole; Clarithromycin | Oral form | 3004.20.31 |
| 28 | Finished drug product containing: Dextromethorphan hydrobromide; Anhydrous caffeine; dl-Methylephedrine hydrochloride; Guaifenesin; Chlorpheniramine maleate | Soft capsule | 3004.90.59 |
| 29 | Finished pharmaceutical product containing: Valsartan; Hydrochlorothiazide | All forms | 3004.90.89 |
| 30 | Finished pharmaceutical product containing: Glucosamine sulphate; Chondroitin sulphate | All forms | 3004.90.99 |
| 31 | Finished pharmaceutical product containing: Econazole; Triamcinolone; Gentamycin | Cream for external use | 3004.20.99 |
| 32 | Finished drug product containing: Dextromethorphan HBr; Chlorpheniramine maleate; Guaifenesin; Pseudoephedrine HCl | Syrup | 3004.42.00 |
| 33 | Finished pharmaceutical product containing: L-Arginine Hydrochloride; L-Histidine Hydrochloride H20; L-Isoleucine; L-Leucine; L-Lysine HCl; L-Methionine; L-Phenylalanine... | Intravenous infusion solution | 3004.90.99 |
| 34 | Finished drug product containing: Betamethasone valerate; Neomycin sulphate | All forms | 3004.10.20 |
| 35 | Finished pharmaceutical product containing: Miconazole; Neomycin Sulphate; Betamethasone | All forms | 3004.10.20 |
| 36 | Finished pharmaceutical product containing: Sodium Citrate; Sodium Lauryl Sulphate; Glycerin | All forms | 3004.90.99 |
| 37 | Finished pharmaceutical product containing: Rabeprazole; Ornidazole; Clarithromycin | Oral combination kit | 3004.20.31 |
| 38 | Finished drug product containing: Clindamycin; Clotrimazole | Soft vaginal capsule | 3004.20.99 |
| 39 | Finished pharmaceutical product containing: Lisinopril; Hydrochlorothiazide | Oral form | 3004.90.89 |
| 40 | Finished pharmaceutical product containing: Glycyrrhizin; L-cysteine hydrochloride; Glycine | Injection form | 3004.90.99 |
| 41 | Finished pharmaceutical product containing: Dicyclomine; Simethicone | Oral form | 3004.90.99 |
| 42 | Finished pharmaceutical product containing: Diphenhydramine HCl; Ammonium chloride | Syrup | 3004.90.59 |
| 43 | Finished drug product containing: Azintamide; Pancreatin; Cellulase 4000; Simethicone | Tablet | 3004.90.99 |
| 44 | Finished pharmaceutical product containing: Salbutamol; Bromhexine; Guaiphenesin | Oral form | 3004.90.93 |
| 45 | Finished pharmaceutical product containing: Imipenem; Cilastatin | Powder for injection | 3004.20.99 |
| 46 | Finished drug product containing: Ambroxol HCl; Clenbuterol HCl | Oral form | 3004.90.99 |
| 47 | Finished pharmaceutical product containing: Diphenhydramine HCl; Ammonium Chloride; Sodium Citrate | Syrup | 3004.90.59 |
| 48 | Finished drug product containing: Ascorbic acid; Biotin; Calcium carbonate; Calcium pantothenate; Vitamin B12; WS Spray Dried (PI 1426) E | Oral form | 3004.50.21 |
| 49 | Finished drug product containing: Betamethasone; Dexchlorpheniramine maleate | All forms | 3004.32.90 |
| 50 | Finished drug product containing: Acetaminophen; Tramadol HCl | Oral form | 3004.90.51 |
| 51 | Finished drug product containing: Dexamethasone; Camphor; Menthol | Skin cream | 3004.32.10 |
| 52 | Finished drug product containing: Chloramphenicol; Dexamethasone disodium phosphate; Tetrahydrozoline hydrochloride | Eye drops | 3004.20.79 |
| 53 | Finished pharmaceutical product containing: L-Cystine; Choline hydrogen tartrate | Oral form | 3004.90.99 |
| 54 | Finished pharmaceutical product containing: Thiamine HCl; Riboflavin-5-phosphate sodium; Pyridoxine HCl; Niacinamide; d-Panthenol; Ascorbic acid; Dextrose | Infusion solution | 3004.50.29 |
| 55 | Finished pharmaceutical product containing: Neomycin sulfate; Nystatin; polymyxin B sulfate | Vaginal suppository | 3004.10.20 |
| 56 | Finished pharmaceutical product containing: L-ornithine L-aspartate; Garlic extract; Tocopherol Acetate | Oral form | 3004.50.99 |
| 57 | Finished pharmaceutical product containing: Thiamine, Pyridoxine; Cyanocobalamin | Injection form | 3004.50.29 |
| 58 | Finished drug product containing: Calcium carbonate; Vitamin D3 | Suitable for children, in syrup form | 3004.50.10 |
| 58 | Finished drug product containing: Calcium carbonate; Vitamin D3 | Other forms | 3004.50.99 |
| 59 | Finished drug product containing: Ciprofloxacin; Dexamethasone | Eye drops | 3004.20.99 |
| 60 | Finished pharmaceutical product containing: Terbutaline Sulphate; Bromhexine hydrochloride; Guaifenesin; Menthol | Syrup | 3004.90.59 |
| 61 | Finished drug product containing: Calcium carbonate; Calcium lactate gluconate, cholecalciferol | Oral form | 3004.50.99 |
| 62 | Finished pharmaceutical product containing: Dihydrocodeine bitartrate; Guaifenesin; Dl-methylephedrine HCl; Chlorpheniramine maleate | Oral form | 3004.49.11 |
| 63 | Finished pharmaceutical product containing: Evening primrose oil, calcium (as carbonate); vitamin D3 | Oral form | 3004.50.99 |
| 64 | Finished drug product containing: Clotrimazole; Selenium sulfide | Oral form | 3004.90.99 |
| 65 | Finished drug product containing: Clotrimazole; Miconazole nitrate; Ornidazole | Vaginal suppository | 3004.20.99 |
| 66 | Finished pharmaceutical product containing: Doxylamine succinate; Pyridoxine hydrochloride | Oral form | 3004.50.91 |
| 67 | Finished pharmaceutical product containing: Beta carotene emulsion 30%; tocopherol acetate, ascorbic acid, selenium powder, ubidecarenone, zinc oxide | Oral form | 3004.50.21 |
| 68 | Finished pharmaceutical product containing: Glucosamine sulphate; Chondroitin sulphate, omega 3 -fish oil | All forms | 3004.90.99 |
| 69 | Finished pharmaceutical product containing: Sabalis serrulatae fructus; Solidaginis herba; Hippocastani semen | Tablet | 3004.90.98 |
| 70 | Finished drug product containing: Cefoperazone; Sulbactam | Powder for solution for intramuscular or intravenous injection | 3004.20.99 |
| 71 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-Lysine Monoacetate; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-Arginine; L-Histidine; Glycine; L-Alanine; L-Proline; L-Serine; Cysteine HCl | Intravenous infusion fluid | 3004.90.99 |
| 72 | Finished drug product containing: Betamethasone; Gentamicin | Cream | 3004.32.90 |
| 73 | Finished drug product containing: Ciprofloxacin hydrochloride; Benzalkonium chloride | Ointment form | 3004.20.91 |
| 74 | Finished drug product containing: Candesartan cilexetil; Hydrochlorothiazide | Tablet | 3004.90.89 |
| 75 | Finished drug product containing: Clindamycin; Miconazole | Vaginal suppository | 3004.20.99 |
| 76 | Finished pharmaceutical product containing: Levodopa; Carbidopa | Film-coated tablet | 3004.90.99 |
| 77 | Finished pharmaceutical product containing: Sulfamethoxazole; Trimethoprim | Oral form | 3004.20.10 |
| 78 | Finished drug product containing: Codeine phosphate; Glyceryl guaiacolate | Oral form | 3004.49.11 |
| 79 | Finished drug product containing Paracetamol, Chlorpheniramine | Tablet | 3004.90.51 |
| 80 | Finished pharmaceutical product containing: Solution A: Glucose; Solution B: Amino acid solution; L-Alanine; L-Arginine; L-Aspartic acid; L-Glutamic acid; Glycine; L-Histidine; L-Isoleucine; L-Lysine HCl; L-Methionine | Peripheral intravenous infusion emulsion | 3004.90.99 |
| 81 | Finished pharmaceutical product containing: Ipratropium bromide; Salbutamol sulphate | Aerosol form | 3004.90.93 |
| 82 | Finished pharmaceutical product containing: Lamivudine; Zidovudine | Oral form | 3004.90.82 |
| 83 | Finished pharmaceutical product containing: Sodium lactate solution (60% w/w); Sodium Chloride; | Infusion solution | 3004.90.91 |
| 84 | Finished drug product containing Paracetamol; Ibuprofen | Tablet | 3004.90.54 |
| 85 | Finished pharmaceutical product containing: Mentha oil; eucalyptus oil; lavender oil | Topical patches | 3005.10.10 |
| 86 | Finished pharmaceutical product containing: Pancreatin | Oral form | 3004.90.99 |
| 87 | Finished pharmaceutical product containing: Magaldrate; Simethicone | Chewable tablet | 3004.90.99 |
| 88 | Finished drug product containing: Chlorpheniramine maleate; Dextromethorphan HBr; | Soft capsule | 3004.90.59 . |
| 89 | Finished drug product containing: Cholecalciferol; Oystershell powder | Oral form | 3004.50.99 |
| 90 | Finished drug product containing: Calcipotriol; Betamethasone | All forms | 3004.32.90 |
| 91 | Finished pharmaceutical product containing: Flupentixol dihydrochloride; Melitracen hydrochloride | Oral form | 3004.90.99 |
| 92 | Finished drug product containing: Clotrimazole; Beclomethasone; Gentamicin, Clioquinol | Cream | 3004.32.90 |
| 93 | Finished drug product containing: Benzalkonium chloride; Chlorhexidine digluconate | Foaming solution for topical use | 3004.90.30 |
| 94 | Finished pharmaceutical product containing: Gentamycin; Dexamethasone | Eye drops/ear drops | 3004.20.99 |
| 95 | Finished pharmaceutical product containing: Glycerol; Vaseline; liquid paraffin | Cream | 3004.90.99 |
| 96 | Finished pharmaceutical product containing: Hydroxy propyl methyl cellulose; dextran 70 | Eye drop solution | 3004.90.99 |
| 97 | Finished drug product containing: Bromhexine HCl; Dextromethorphan HBr; Guaifenesin | Soft capsule | 3004.90.59 |
| 98 | Finished pharmaceutical product containing: Ethinylestradiol; Cyproterone acetate | Oral form | 3004.39.00 |
| 99 | Finished pharmaceutical product containing: Pepsin; Diastase (Alpha Amylase) (1:1200); Dried brewer's yeast | Capsule | 3004.90.99 |
| 100 | Finished pharmaceutical product containing: Neomycin; Gramicidin; fludrocortisone acetate | Eye drops | 3004.10.20 |
| 101 | Finished pharmaceutical product containing: Levonorgestrel (D-Norgestrel); Ethinylestradiol | Oral form | 3004.39.00 |
| 102 | Finished pharmaceutical product containing: Losartan potassium; Hydrochlorothiazide | Oral form | 3004.90.89 |
| 103 | Finished pharmaceutical product containing: Dobutamine Hydrochloride; Dextrose | Infusion solution | 3004.90.89 |
| 104 | Finished pharmaceutical product containing: Diclofenac sodium; Pyridoxol HCl; Thiamine nitrate; Vitamin B12 | Oral form | 3004. 50. 21 |
| 105 | Finished pharmaceutical product containing: Drospirenone; Ethinyl estradiol | Film-coated tablet | 3004.39.00 |
| 106 | Finished pharmaceutical product containing: Sodium chloride; Sodium lactate; Potassium chloride; Calcium chloride. 2H2O | Infusion form | 3004.90.91 |
| 107 | Finished drug product containing: Clindamycin; Benzoyl peroxide | Gel bôi da | 3004.20.99 |
| 108 | Finished drug product containing: Clopidogrel hydrogen sulfate form II; acetylsalicylic acid combined with corn starch | Film-coated tablet | 3004.90.89 |
| 109 | Finished pharmaceutical product containing: Glyburide; Metformin hydrochloride | Tablet | 3004.90.89 |
| 110 | Finished pharmaceutical product containing: L-menthol, methyl salicylate; Dl-camphor; thymol, borneol; diphenhydramine | Plaster | 3005.10.10 |
| 111 | Finished drug product containing Paracetamol; ascorbic acid | Effervescent tablet | 3004.50.91 |
| 112 | Finished pharmaceutical product containing: Synthetic retinol concentrate; Thiamine Nitrate; Hydrochloride; Nicotinamide; Colecalciferol; Riboflavin; Calcium Pantothenate | Sugar-coated tablet | 3004.50.21 |
| 113 | Finished pharmaceutical product containing: Tenofovir disoproxil fumarate; Emtricitabine | Oral form | 3004.90.82 |
| 114 | Finished pharmaceutical product containing: Enalapril maleate; Hydrochlorothiazide | Tablet | 3004.90.89 |
| 115 | Finished drug product containing: Valproic acid; Sodium valproate | Controlled-release film-coated tablet | 3004.90.99 |
| 116 | Finished pharmaceutical product containing: Sodium bicarbonate; Citric acid Anhydrous; Sodium carbonate | Effervescent powder | 3004.90.99 |
| 117 | Finished pharmaceutical product containing: Pancreatin; Fellis bovis extract; Hemicellulase | Enteric-coated tablet | 3004.90.99 |
| 118 | Finished drug product containing: Amoxicillin; Potassium clavulanate | Oral form | 3004.10.16 |
| 118 | Finished drug product containing: Amoxicillin; Potassium clavulanate | Other forms | 3004.10.19 |
| 119 | Finished drug product containing: Adapalene; Benzoyl peroxide | Gel | 3004.90.99 |
| 120 | Finished drug product containing: Adenosine triphosphate; Cocarboxylase; Cyanocobalamin; Nicotinamide | Lyophilized powder for injection | 3004.50.21 |
| 121 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-Lysine acetate; L-Methionine; N-Acetyl-L-Cysteine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-Arginine; L-Histidine; Aminoacetic acid; L-Alanine; L-Proline; L-Serine | Infusion solution | 3004.90.99 |
| 122 | Finished drug product containing: Desogestrel; Ethinyl estradiol | Oral form | 3004.39.00 |
| 123 | Finished pharmaceutical product containing: Piperaquine tetraphosphate; Dihydroartemisinin | Oral form | 3004.60.10 |
| 124 | Finished drug product containing: Ascorbic acid; calcium pantothenate; L-cysteine | Oral form | 3004.50.21 |
| 125 | Finished pharmaceutical product containing: Vitamin A; Vitamin C, Vitamin E | Oral form | 3004.50.21 |
| 126 | Finished drug product containing: Dextrose monohydrate; Sodium chloride; Sodium lactate; Potassium chloride; Calcium chloride.2H2O; Magnesium chloride hexahydrate; sodium metabisulfite | Peritoneal dialysis solution | 3004.90.91 |
| 127 | Finished pharmaceutical product containing: Dextrose; Sodium Chloride; Sodium metabisulfite; Potassium Acetate; Magnesium Acetate | Infusion fluid | 3004.90.91 |
| 128 | Finished pharmaceutical product containing: Dextrose monohydrate; Sodium Chloride; Sodium metabisulfite; Potassium Acetate; Magnesium Acetate; Sodium Acetate | Infusion fluid | 3004.90.91 |
| 129 | Finished pharmaceutical product containing: Potassium Iodide; sodium iodide | Eye drops | 3004.90.99 |
| 130 | Finished pharmaceutical product containing: Gadopentetate meglumine; Meglumine | Injection form | 3004.90.99 |
| 131 | Finished pharmaceutical product containing: Iron (III) hydroxide polymaltose; Folic acid | Chewable tablet | 3004.50.91 |
| 132 | Finished pharmaceutical product containing: chlormadinone acetate; ethinyl estradiol | Film-coated tablet | 3004.39.00 |
| 133 | Finished pharmaceutical product containing: Estradiol; Dydrogesterone | Film-coated tablet | 3004.39.00 |
| 134 | Finished pharmaceutical product containing: pancreatin; hemicellulase; Ox bile; simethicone | enteric-coated tablet | 3004.90.99 |
| 135 | Finished pharmaceutical product containing: Levofloxacin hemihydrate; Dexamethasone sodium phosphate | Eye drops | 3004.20.99 |
| 136 | Finished pharmaceutical product containing: Fluocinolone Acetonide; Ciclopirox Olamine | Skin cream | 3004.32.40 |
| 137 | Finished pharmaceutical product containing: Fluconazole; Tinidazole | Combination kit containing capsules, film-coated tablets | 3004.20.99 |
| 138 | Finished drug product containing: Fusidic acid; Betamethasone | All forms | 3004.32.90 |
| 139 | Finished drug product containing: Folic acid; Ferrous fumarate | Oral form | 3004.50.91 |
| 140 | Finished drug product containing: Anhydrous sodium sulfate; Sodium bicarbonate; Sodium chloride; Potassium chloride | Powder for oral solution | 3004.90.99 |
| 141 | Finished pharmaceutical product containing: Glucosamine sulphate potassium chloride; Methyl sulphonyl Methane | All forms | 3004.90.99 |
| 142 | Finished pharmaceutical product containing: Ferrous Fumarate; folic acid; vitamin B12 | Oral form | 3004.50.21 |
| 143 | Finished pharmaceutical product containing: Propyphenazone; Diphenylhydramine HCl; Adiphenyl HCl | Oral form | 3004.90.59 |
| 144 | Finished drug product containing: Azithromycin; Secnidazole; Fluconazole | Oral form | 3004.20.91 |
| 145 | Finished pharmaceutical product containing: Thiamine Hydrochloride; Riboflavin; Nicotinamide; Calcium Pantothenate | Oral form | 3004.50.21 |
| 146 | Finished pharmaceutical product containing: Vildagliptin; Metformin HCl | Oral form | 3004.90.89 |
| 147 | Finished drug product containing: Bimatoprost; Timolol | Eye drops | 3004.90.99 |
| 148 | Finished drug product containing: Ursodeoxycholic acid; Thiamine HCl; Riboflavin | Soft capsule | 3004.50.21 |
| 149 | Finished drug product containing: Alpha-amylase; papain; simethicone | Oral form | 3004.90.99 |
| 150 | Finished drug product containing: Sodium alginate; Sodium bicarbonate; Calcium carbonate | Oral suspension | 3004.90.99 |
| 151 | Finished pharmaceutical product containing: Anhydrous gelatin (as modified gelatin); NaCl; Magnesium chloride hexahydrate; KCl; Sodium lactate (as sodium (S)-lactate solution) | Injection form | 3004.90.91 |
| 152 | Finished pharmaceutical product containing: Hypromellose; Carbomer | Eye drops | 3004.90.99 |
| 153 | Finished drug product containing: Betamethasone; Clotrimazole; Gentamicin | Kern | 3004.32.90 |
| 154 | Finished drug product containing: Acetaminophen; Isopropylantipyrine; Anhydrous caffeine | Oral form | 3004.90.51 |
| 155 | Finished pharmaceutical product containing: Gliclazide; Metformin Hydrochloride | Oral form | 3004.90.89 |
| 156 | Finished drug product containing: Clobetasol; Neomycin | Cream for external use | 3004.10.20 |
| 157 | Finished pharmaceutical product containing: Metformin HCl; Glibenclamide | Oral form | 3004.90.89 |
| 158 | Finished drug product containing: Ursodeoxycholic acid; Taurine; white ginseng extract, Thiamine nitrate, Inositol | Soft capsule | 3004.90.99 |
| 159 | Finished pharmaceutical product containing: Gramicidin S; Lidocaine HCl | Lozenge | 3004.20.99 |
| 160 | Finished pharmaceutical product containing: Gestodene; Ethinyl estradiol | Oral form | 3004.39.00 |
| 161 | Finished pharmaceutical product containing: Lactobacillus acidophilus 100.000.000 - 10.000.000.000 cfu; Estriol 0,03mg | Vaginal suppository | 3004.39.00 |
| 162 | Finished pharmaceutical product containing: Folic acid; iron fumarate; Cyanocobalamin; zinc sulfate monohydrate | Oral form | 3004.50.21 |
| 163 | Finished pharmaceutical product containing: Iron fumarate, Pyridoxine HCl; Zinc sulfate; Cyanocobalamin; Folic acid | Oral form | 3004.50.21 |
| 164 | Finished pharmaceutical product containing: Ketoconazole; Clobetasol propionate | Topical preparations | 3004.32.10 |
| 165 | Finished pharmaceutical product containing: Pheniramine maleate; Naphazoline hydrochloride | Eye drops | 3004.90.99 |
| 166 | Finished drug product containing: Beta carotene; dl-alpha tocopherol; Ascorbic acid; Selenium in dried yeast | Oral form | 3004.50.21 |
| 167 | Finished pharmaceutical product containing: Tribasic calcium phosphate; Vitamin A; Vitamin A + D3 | Oral form | 3004.50.21 |
| 168 | Finished pharmaceutical product containing: Diosmin; Hesperidin | Film-coated tablet | 3004.90.99 |
| 169 | Finished pharmaceutical product containing: L-Cysteine; Choline bitartrate | Oral form | 3004.90.99 |
| 170 | Finished drug product containing: Cardus marianus extract, Thiamine nitrate, Nicotinamide, Calcium pantothenate, Vitamin B12; B2, B6 | Oral form | 3004.50.21 |
| 171 | Finished pharmaceutical product containing: Meglumine ioxaglate; Sodium ioxaglate | Injection form | 3004.90.99 |
| 172 | Finished drug product containing: Crataegus extract; Ginkgo biloba extract; Melissa extract; Garlic oil | Oral form | 3004.90.98 |
| 173 | Finished pharmaceutical product containing: Glucosamine sulfate; Chondroitin sulfate, Calcium Carbonate, Vitamin C | Oral form | 3004.50.91 |
| 174 | Finished pharmaceutical product containing: Riboflavin; Nicotinamide; Pyridoxal phosphate; Biotin; Dried coix seed ex. | Oral form | 3004.50.21 |
| 175 | Finished drug product containing: Betamethasone; Salicylic acid | All forms | 3004.32.90 |
| 176 | Finished drug product containing: Aluminium hydroxide; Magnesium hydroxide, Simethicone | Oral form | 3004.90.99 |
| 177 | Finished pharmaceutical product containing: Dextrose; D-Panthenol; Vitamins B1; B2; B6; C; PP | Infusion solution | 3004.50.29 |
| 178 | Finished drug product containing: Cyanocobalamin; Chlorpheniramine maleate; Naphazoline HCl | Eye drops | 3004.50.91 |
| 179 | Finished pharmaceutical product containing: Lactobacillus acidophilus; Lactobacillus bifidus; Streptococcus faecalis | Oral form | 3004.90.99 |
| 180 | Finished pharmaceutical product containing: Precipitated Calcium carbonate; concentrated Cholecalciferol | Oral form | 3004.50.99 |
| 181 | Finished drug product containing: Amlodipine; Atenolol | All forms | 3004.90.89 |
| 182 | Finished pharmaceutical product containing: Tilbroquinol; Tiliquinol; Tiliquinol laurylsulfate | Oral form | 3004.90.99 |
| 183 | Finished pharmaceutical product containing: Purified soybean oil; Purified yolk lecithin | Infusion form | 3004.90.99 |
| 184 | Finished pharmaceutical product containing: Iron (III) Hydroxide Polymaltose; Folic Acid; Ascorbic acid | Oral form | 3004.50.21 |
| 185 | Finished pharmaceutical product containing: Metronidazole; Miconazole nitrate, Lactobacillus acidophilus | Vaginal suppository | 3004.20.99 |
| 186 | Finished pharmaceutical product containing: Sitagliptin phosphate monohydrate; Metformin HCl | Oral form | 3004.90.89 |
| 187 | Finished pharmaceutical product containing: Lidocaine HCl; chamomile flower extract | Gel | 3004.90.49 |
| 188 | Finished pharmaceutical product containing: Ketoconazole; Zinc Pyrithione | Injection form | 3004.90.99 |
| 189 | Finished pharmaceutical product containing: L-Leucine; L-Isoleucine; Lysine Hydrochloride; L-Phenylalanine; L-Threonine; L-Valine; L-Tryptophan; L-Histidine HCl.H2O; L-Methionine | Green rice flakes | 3004.90.99 |
| 190 | Finished pharmaceutical product containing: Saxagliptin; Metformin Hydrochloride | Oral form | 3004.90.89 |
| 191 | Finished drug product containing: Artemether; Lumefantrine | Oral form | 3004.90.64 |
| 192 | Finished drug product containing: Dextromethorphan; Glyceryl guaiacolate (guaifenesin); Chlorpheniramine maleate | Syrup | 3004.90.59 |
| 193 | Finished drug product containing: Aluminium hydroxide; Magnesium trisilicate 4.8-6.2H2O; Activated dimethylpolysiloxane | Oral form | 3004.90.99 |
| 194 | Finished pharmaceutical product containing: Iron III Hydroxide Polymaltose; Folic Acid | Oral form | 3004.50.91 |
| 195 | Finished pharmaceutical product containing: Precipitated Calcium carbonate; Cholecalciferol | Oral form | 3004.50.99 |
| 196 | Finished pharmaceutical product containing: Latanoprost; Timolol maleate | Eye drops | 3004.90.99 |
| 197 | Finished pharmaceutical product containing: Lactobacillus LB 5 billion; fermentation culture medium 80mg in 170mg powder | Oral form | 3004.90.99 |
| 198 | Finished pharmaceutical product containing: Lactobacillus LB 10 billion; fermentation culture medium 160mg in 340mg powder | Oral form | 3004.90.99 |
| 199 | Finished pharmaceutical product containing: Lactobacillus acidophilus; Lactobacillus Bulgaricus | Oral form | 3004.90.99 |
| 200 | Finished pharmaceutical product containing: Lamivudine; Nevirapine; Zidovudine | Oral form | 3004.90.82 |
| 201 | Finished pharmaceutical product containing: Macrogol 4000; Anhydrous Sodium sulfate; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride | Oral form | 3004.90.99 |
| 202 | Finished drug product containing: Chlordiazepoxide; Clidinium bromide | Oral form | 3004.90.99 |
| 203 | Finished pharmaceutical product containing: Lidocaine HCl; Epinephrine bitartrate | Injection form | 3004.90.49 |
| 204 | Finished pharmaceutical product containing: Medium-chain triglycerides; Soya-bean oil, refined; Omega-3-acid triglycerides | Infusion form | 3004.90.99 |
| 205 | Finished pharmaceutical product containing: Soyabean oil; Egg Lecithin; Glycerol | Intravenous infusion emulsion | 3004.90.99 |
| 206 | Finished drug product containing: DL-Methionine; Cysteine hydrochloride | Oral form | 3004.90.99 |
| 207 | Finished pharmaceutical product containing: Fluomethasone pivalate; Clioquinol | Ointment | 3004.32.90 |
| 208 | Finished pharmaceutical product containing: Levodopa; Benserazide HCl | Tablet | 3004.90.99 |
| 209 | Finished pharmaceutical product containing: Magnesium trisilicate; Dry Aluminium hydroxide; Simethicone | Oral form | 3004.90.99 |
| 210 | Finished drug product containing: Folic acid 0.35mg; Iron (III) hydroxide polymaltose complex 357mg | Chewable tablet | 3004.50.91 |
| 211 | Finished drug product containing: DL-Methionine; L-Leucine; L-Valine; L-Isoleucine; L-Threonine; L-Tryptophan; L-Phenylalanine; Lysine HCl; Retinol palmitate; Ergocalciferol; Tocopherol acetate; Thiamine nitrate; Riboflavin; Nicotinamide; Pyridoxine HCl; Calcium pantothenate; Cyanocobalamin | Oral form | 3004.50.21 |
| 212 | Finished drug product containing: Dextromethorphan HBr; Potassium cresolsulfonate; Lysozyme chloride | Capsule | 3004.90.59 |
| 213 | Finished drug product containing Paracetamol; Lidocaine | Injection form | 3004.90.59 |
| 214 | Finished pharmaceutical product containing: Erythromycin; Tretinoin | Gel bôi ngoài da | 3004.20.39300 4. 20. 32 |
| 215 | Finished drug product containing: Bacillus subtilis; Streptococcus faecium | Oral form | 3004.90.99 |
| 216 | Finished drug product containing: Crataegus oxyacantha leaf dry extract; Melissa folium dry extract; Ginkgo biloba leaf dry extract; Garlic oil | Oral form | 3004.90.98 |
| 217 | Finished drug product containing: Amoxicillin; Clavulanic acid | Powder for injection | 3004.10.19 |
| 218 | Finished drug product containing: Alverine citrate; Simethicone | Oral form | 3004.90.99 |
| 219 | Finished pharmaceutical product containing: Metronidazole; Povidone-Iodine | Topical preparations | 3004.20.99 |
| 220 | Finished pharmaceutical product containing: Glucose; Amino acids; Fat Emulsion | Infusion solution | 3004.90.91 |
| 221 | Finished drug product containing: Vitamins B1; B2; B6; B12; PP; Dexpanthenol; Biotin | Injection form | 3004.50.29 |
| 222 | Finished drug product containing: Allantoin; pyridoxine HCl; Tocopherol acetate; aminoethyl sulfonic acid; sodium chondroitin sulfate | Eye drops | 3004.50.29 |
| 223 | Finished pharmaceutical product containing: Glucose; fat emulsion; amino acids; electrolytes | Infusion form | 3004.90.91 |
| 224 | Finished pharmaceutical product containing: Iron sulfate; Folic acid | Oral form | 3004.50.91 |
| 225 | Finished pharmaceutical product containing: Mometasone Furoate; Salicylic acid | Ointment | 3004.32.90 |
| 226 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-Lysine acetate; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-alanine, L-Arginine; L-Aspartic acid, L-Glutamic acid, L-Histidine, L-Proline,... | intravenous injection | 3004.90.99 |
| 227 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; Lysine acetate; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-Alanine; L-Arginine; L-Aspartic acid; L-cysteine; L-.... | Infusion emulsion | 3004.90.99 |
| 228 | Finished pharmaceutical product containing: Thiamine hydrochloride; Riboflavin; Pyridoxine hydrochloride; Nicotinamide | Oral form | 3004.50.10 |
| 229 | Finished pharmaceutical product containing: Vitamin A Acetate, Vitamin D3, Vitamin B1, Vitamin B2, Vitamin B6, Nicotinamide, Cyanocobalamin, Calcium Pantothenate, Folic acid, Vitamin C, Vitamin E, Ferrous sulphate, Cupric sulphate, Manganese sulphate, Zinc sulphate; Potassium iodide; Potassium sulphate | Oral form | 3004.50.21 |
| 230 | Finished pharmaceutical product containing: Tropicamide; Phenylephrine HCl | Eye drops | 3004.49.90 |
| 231 | Finished drug product containing: Chlorpheniramine; Dextromethorphan; Phenylephrine | Soft capsule | 3004.90.59 |
| 232 | Finished pharmaceutical product containing: Dextrose; D-Pantothenol; Ascorbic acid; Thiamine hydrochloride; Riboflavin; Niacinamide; Pyridoxine hydrochloride | Intravenous infusion solution | 3004.50.29 |
| 233 | Finished pharmaceutical product containing: Magnesium Lactate; Pyridoxine hydrochloride | Oral form | 3004.50.91 |
| 234 | Finished pharmaceutical product containing: Metformin Hydrochloride; Glimepiride | Oral form | 3004.90.89 |
| 235 | Finished drug product containing: Clotrimazole; Gentamicin sulfate; Beclomethasone dipropionate | Skin cream | 3004.32.90 |
| 236 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-Lysine acetate; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-alanine, L-Arginine; L-Aspartic acid, L-Glutamic acid, L-Histidine, L-Proline,... | intravenous injection | 3004.90.99 |
| 237 | Finished drug product containing: Codeine base (as codeine camphosulfonate); Sulfoguaiacol; Grindelia soft extract | Oral form | 3004.49.11 |
| 238 | Finished pharmaceutical product containing: Metronidazole; Miconazole nitrate | Vaginal suppository | 3004.20.99 |
| 239 | Finished drug product containing: Alpha-amylase; papain; dill oil, anise oil, caraway oil | Oral form | 3004.90.99 |
| 240 | Finished drug product containing: Alpha amylase; Papain | Liquid medicine | 3004.90.99 |
| 241 | Finished pharmaceutical product containing: Metronidazole; Neomycin sulfate; Nystatin | Vaginal suppository | 3004.10.20 |
| 242 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-Lysine Acetate; L-Methionine; L-Phenylalanine; L-Threonine; L-Tryptophan; L-Valine; L-Histidine; L-cysteine.HCl.2H2O; Sodium Bisulfite; Disodium Edetate | Infusion solution | 3004.90.99 |
| 243 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-alanine, L-Arginine; L-Methionine; L-phenylalanine; L-Proline,... | Solution for intravenous infusion | 3004.90.99 |
| 244 | Finished drug product containing: Cytidine-5'-monophosphate disodium (CMP, disodium salt); Uridine-5'-triphosphate trisodium (UTP, sodium salt) + Uridine-5'-diphosphate disodium (UDP, sodium salt) + Uridine-5'-monophosphate disodium (UMP, sodium salt) | Injection form | 3004.90.99 |
| 245 | Finished drug product containing: Cytidine-5-disodium monophosphate; Uridine-5-trisodium triphosphate; Uridine-5-disodium diphosphate; Uridine-5-disodium monophosphate | Oral form | 3004.90.99 |
| 246 | Finished drug product containing: Cytidine-5-disodium monophosphate; Uridine-5-trisodium triphosphate; Uridine-5-disodium diphosphate; Uridine-5-disodium monophosphate | Injection form | 3004.90.99 |
| 247 | Finished drug product containing: Carbonyl iron; Folic acid; B12; Vitamin C; Zinc sulphate | Oral form | 3004.50.21 |
| 248 | Finished pharmaceutical product containing: Lutein; Zeaxanthin; Ascorbic acid; alpha-tocopheryl acetate; Selenium; Zinc | Oral form | 3004.50.21 |
| 249 | Finished pharmaceutical product containing: Dihydroergocristine mesylate 333,0mcg; Dihydroergocryptine mesylate 333,0mcg; Dihydroergocornine mesylate 333,0mcg (equivalent to Dihydroergotoxine mesylate 1 mg) | Oral form | 3004.49.90 |
| 250 | Finished pharmaceutical product containing: Olmesartan medoxomil; Hydrochlorothiazide | Oral form | 3004.90.89 |
| 251 | Finished pharmaceutical product containing: Oxethazaine; Anhydrous aluminium hydroxide gel; Magnesium hydroxide | Oral form | 3004.90.99 |
| 252 | Finished pharmaceutical product containing: Polymyxin B sulfate; Neomycin sulfate; Gramicidin | Eye drops | 3004.10.20 |
| 253 | Finished drug product containing: Sodium carboxymethylcellulose; Glycerin; polysorbate | Eye drops | 3004.90.99 |
| 254 | Finished pharmaceutical product containing: Ofloxacin; Hydroxy PropylMethylCellulose | Eye drops | 3004.20.99 |
| 255 | Finished pharmaceutical product containing: Dried aluminium hydroxide gel; Magnesium trisilicate, Magnesium Hydroxide, Simethicone | Chewable tablet | 3004.90.99 |
| 256 | Finished drug product containing: Calcium; Alfacalcidol | Oral form | 3004.50.99 |
| 257 | Finished pharmaceutical product containing: Phenazone; Lidocaine HCl | Ear drop solution | 3004.90.49 |
| 258 | Finished pharmaceutical product containing: Dimethicone; Dried Aluminium hydroxide gel; Magnesium hydroxide | Chewable tablet | 3004.90.99 |
| 259 | Finished drug product containing: Chlorpheniramine maleate; DL-Methylephedrine HCl, Dextromethorphan HBr | Capsule | 3004.49.90 |
| 260 | Finished drug product containing: Beta carotene; natural Vitamin E; Selenium, alpha lipoic acid | Oral form | 3004.50.21 |
| 261 | Finished pharmaceutical product containing: Pantoprazole Sodium sesquihydrate; Clarithromycin; Amoxicillin Trihydrate | Oral form | 3004.10.16 |
| 262 | Finished drug product containing Paracetamol; Phenylephrine hydrochloride; Noscapine; Caffeine; Vitamin C; Terpin Hydrate | Tablet | 3004.90.51 |
| 263 | Finished drug product containing Paracetamol; Caffeine | Effervescent tablet | 3004.90.51 |
| 264 | Finished pharmaceutical product containing: Magnesium aspartate; Potassium aspartate | Injection form | 3004.90.99 |
| 265 | Finished pharmaceutical product containing: Magnesium aspartate tetrahydrate; Potassium aspartate hemihydrate | Oral form | 3004.90.99 |
| 266 | Finished pharmaceutical product containing: Pancreatin; Dimethicone | Tablet | 3004.90.99 |
| 267 | Finished drug product containing Paracetamol; thiamine nitrate; chlorpheniramine maleate | Granules for oral suspension | 3004.90.51 |
| 268 | Finished pharmaceutical product containing: Pantoprazole; Tinidazole; Clarithromycin | Combination kit containing film-coated tablets | 3004.20.31 |
| 269 | Finished pharmaceutical product containing: Sulfogaiacol; Sodium benzoate | Syrup | 3004.90.59 |
| 270 | Finished pharmaceutical product containing: Neomycin Sulfate; Bacitracin Zinc; Amylocaine HCl | Lozenge tablet | 3004.10.20 |
| 271 | Finished pharmaceutical product containing: Vitamin B9 (Folic acid); Vitamin B12 (Cyanocobalamin); Biotin; Ferrous fumarate; Ascorbic acid | Oral form | 3004.50.21 |
| 272 | Finished pharmaceutical product containing: Sodium chloride; Tri-sodium citrate dihydrate; potassium chloride; anhydrous dextrose | Powder for oral use | 3004.90.99 |
| 273 | Finished pharmaceutical product containing: Polyethylene glycol; sodium chloride, potassium chloride, sodium bicarbonate, anhydrous Sodium sulphate | Oral form | 3004.90.99 |
| 274 | Finished drug product containing: Bacillus subtilis; Streptococcus faecium, thiamine HCl, riboflavin, nicotinamide, pyridoxine HCl, Vitamin C, Cyanocobalamin, Ca, Zn | Oral form | 3004.50.21 |
| 275 | Finished pharmaceutical product containing: Dried aluminium hydroxide; Magnesium trisilicate, Magnesium Hydroxide, Simethicone | Chewable tablet | 3004.90.99 |
| 276 | Finished pharmaceutical product containing: Perindopril tert Butylamine; Indapamide | Oral form | 3004.90.89 |
| 277 | Finished pharmaceutical product containing: Metformin Hydrochloride; Pioglitazone Hydrochloride | Oral form | 3004.90.89 |
| 278 | Finished pharmaceutical product containing: Felodipine; Metoprolol succinate | Oral form | 3004.90.89 |
| 279 | Finished drug product containing: Calcium lactate gluconate; Calcium carbonate; Ascorbic acid | Oral form | 3004.50.91 |
| 280 | Finished pharmaceutical product containing: Glucosamine sulfate potassium chloride; Manganese sulfate; | Oral form | 3004.50.21 |
| 281 | Finished pharmaceutical product containing: Natural fish oil (Tuna); Omega-3 marine | Oral form | 3004.50.21 |
| 282 | Finished drug product containing: Dexamethasone sodium phosphate; Ofloxacin | Eye drops | 3004.20.99 |
| 283 | Finished pharmaceutical product containing: Neomycin sulfate; Polymyxin B sulfate; Sodium | Ear drop solution | 3004.10.20 |
| 284 | Finished pharmaceutical product containing: Pantoprazole; Tinidazole | enteric-coated tablet | 3004.20.31 |
| 285 | Finished pharmaceutical product containing: Polymyxin B sulfate; Neomycin sulfate; Dexamethasone[2] | Eye drops | 3004.32.90 |
| 286 | Finished pharmaceutical product containing: Trimebutine; Ruscogenins | Rectal cream | 3004.90.99 |
| 287 | Finished pharmaceutical product containing: Lansoprazole; Amoxicillin; Clarithromycin | Oral form | 3004.10.16 |
| 288 | Finished drug product containing Paracetamol; tramadol | Oral form | 3004. 90. 51 |
| 289 | Finished pharmaceutical product containing: Pinene; Camphene; Borneol; Menthone; Menthol; | Oral form | 3004.90.99 |
| 290 | Finished pharmaceutical product containing: Pinene, Camphene, Borneol, Fenchone; Anethole; | Oral form | 3004.90.99 |
| 291 | Finished pharmaceutical product containing: Thiamine hydrochloride; Riboflavin; Pyridoxine hydrochloride; Nicotinamide; Dexpanthenol; | Injection form | 3004.50.29 |
| 292 | Finished drug product containing: Chloramphenicol; Dexamethasone | Eye drops | 3004.20.79 |
| 293 | Finished pharmaceutical product containing: Ramipril; hydrochlorothiazide | Oral form | 3004.90.89 |
| 294 | Finished pharmaceutical product containing: Sodium succinate; N-(1-deoxy-D-glucitol-1-yl)-N-methylammonium | Infusion form | 3004.90.99 |
| 295 | Finished pharmaceutical product containing: Vitamin C; Zinc | Oral form | 3004.50.91 |
| 296 | Finished drug product containing: Amiloride hydrochloride; Hydrochlorothiazide | Oral form | 3004.90.89 |
| 297 | Finished drug product containing: Carbocisteine; Promethazine HCl | Oral form | 3004.90.59 |
| 298 | Finished drug product containing: Acetaminophen; Dextromethorphan HBr; Phenylephrine HCl | Oral form | 3004. 90. 51 |
| 299 | Finished drug product containing: Acetaminophen; Dextromethorphan HBr; Doxylamine succinate | Oral form | 3004. 90. 51 |
| 300 | Finished drug product containing: Amoxicillin; Potassium clavulanate | Oral form | 3004.10.16 |
| 301 | Finished pharmaceutical product containing: Ethinyl Oestradiol; Levonorgestrel | Coated tablet | 3004.39.00 |
| 302 | Finished pharmaceutical product containing: Sodium Lactate solution, Sodium chloride; Potassium Chloride; Calcium Chloride | Intravenous infusion form | 3004.90.91 |
| 303 | Finished pharmaceutical product containing: Pseudoephedrine HCl; Triprolidine HCl | Oral form | 3004.42.00 |
| 304 | Finished drug product containing: 2,4 Dichlorobenzyl Alcohol; Amylmetacresol; menthol | Lozenge | 3004.90.99 |
| 305 | Finished pharmaceutical product containing: Sodium lactate solution (60% w/w); Sodium Chloride; Potassium Chloride; Calcium Chloride dihydrate | Infusion form | 3004.90.91 |
| 306 | Finished pharmaceutical product containing: Sodium Chloride, Potassium Chloride, Calcium Chloride Dihydrate; Magnesium Chloride Hexahydrate, Sodium Acetate Trihydrate, Malic acid | Infusion form | 3004.90.91 |
| 307 | Finished pharmaceutical product containing: Pinene (alpha + beta); Camphene; Cineol; Menthol; Menthone; Borneol | Oral form | 3004.90.99 |
| 308 | Finished pharmaceutical product containing: Pinene (alpha+beta); Camphene; Cineol BPC (1973); Fenchone; Borneol; Anethole | Oral form | 3004.90.99 |
| 309 | Finished pharmaceutical product containing: Royal Jelly; Aloe extract, retinol acetate, Ferrous fumarate, Magnesium oxide, Zinc oxide, Dibasic calcium phosphate, palm oil | Oral form | 3004.90.98 |
| 310 | Finished pharmaceutical product containing: Neomycin sulfate; Clotrimazole; Metronidazole | Vaginal suppository | 3004.10.20 |
| 311 | Finished pharmaceutical product containing: Methyl salicylate; Turpentine oil; White camphor oil; Cinnamic aldehyde oil; Cinnamon leaf oil | Rubbing oil | 3004.90.55 |
| 312 | Finished pharmaceutical product containing: Salbutamol; Beclomethasone Dipropionate | Nebulizer / aerosol | 3004. 32. 90 |
| 313 | Finished pharmaceutical product containing: Iron Gluconate; Manganese sulfate; Copper sulfate; | Oral form | 3004.90.99 |
| 314 | Finished pharmaceutical product containing: sulphur; Salicylic acid | Medicated soap | 3401.11.40 |
| 315 | Finished drug product containing: Cefixime; Lactic acid bacillus | Oral form | 3004.20.91 |
| 316 | Finished drug product containing: Cod liver oil; Vitamin A and D3 oily concentrate; Calcium hypophosphite | Oral form | 3004.50.21 |
| 317 | Finished drug product containing: Betamethasone; d-Chlorpheniramine maleate | Tablet | 3004.32.90 |
| 318 | Finished drug product containing: Creosote; Powdered geranium herb; Phellodendron bark dry extract | Oral form | 3004.90.98 |
| 319 | Finished pharmaceutical product containing: L-Isoleucine; L-Leucine; L-valine | Film-coated granules | 3004.90.99 |
| 320 | Finished pharmaceutical product containing: Selenium in dried yeast; chromium in dried yeast; ascorbic acid | Oral form | 3004.50.91 |
| 321 | Finished drug product containing: Calcium lactate; Calcium gluconate; Calcium carbonate; ergocalciferol granules | Oral form | 3004.50.99 |
| 322 | Finished pharmaceutical product containing: Sulphamethoxazole; Trimethoprim | Oral form | 3004.20.10 |
| 323 | Finished drug product containing: Articaine hydrochloride; Adrenaline base | Injection solution for dental use | 3004.39.00 |
| 324 | Finished pharmaceutical product containing: Fluticasone propionate; Salmeterol Xinafoate | Metered-dose spray suspension | 3004.32.90 |
| 325 | Finished pharmaceutical product containing: Fluticasone propionate; Salmeterol Xinafoate | Suspension-type inhalation spray for oral inhalation | 3004.32.90 |
| 326 | Finished pharmaceutical product containing: Salmeterol xinafoate; Fluticasone propionate | Metered-dose aerosol spray | 3004.32.90 |
| 327 | Finished drug product containing: Amoxicillin trihydrate; potassium clavulanate | Injection form | 3004.10.19 |
| 328 | Finished drug product containing: Ampicillin sodium; Sulbactam sodium | Injection form | 3004.10.19 |
| 329 | Finished pharmaceutical product containing: Concentrated hydrolyzed liver protein (65%); Concentrated Peptone (65%); Ferric Ammonium citrate (50%v/v); Folic Acid | Oral form | 3004.50.91 |
| 330 | Finished pharmaceutical product containing: L-Cysteine; Choline Hydrogen tartrate | Oral form | 3004.90.99 |
| 331 | Finished drug product containing: Calcium gluconate; Calcium saccharate | Injection form | 3004.90.99 |
| 332 | Finished pharmaceutical product containing: Dimethyl polysiloxane; Magaldrate | Oral form | 3004.90.99 |
| 333 | Finished drug product containing: Calcium lactate; Calcium gluconate hydrate; Calcium carbonate; Anhydrous ergocalciferol | Oral form | 3004.50.99 |
| 334 | Finished pharmaceutical product containing: Gentamycin sulfate; Lidocaine HCl | Injection solution | 3004.20.99 |
| 335 | Finished pharmaceutical product containing: Urea; Vitamin E | Cream for external use | 3004.50.99 |
| 336 | Finished pharmaceutical product containing: Refined soybean oil; Medium chain triglycerides; Refined olive oil; Refined fish oil | Intravenous infusion emulsion | 3004.90.99 |
| 337 | Finished pharmaceutical product containing: Sodium Lactate; Sodium Chloride; Potassium Chloride; Calcium Chloride | Infusion form | 3004.90.91 |
| 338 | Finished drug product containing: Dextromethorphan HBr; Phenylephrine HCl; Chlorpheniramine maleate | Oral form | 3004.90.59 |
| 339 | Finished pharmaceutical product containing: L-cystine; Precipitated sulphur; Retino | Oral form | 3004.50.91 |
| 340 | Finished pharmaceutical product containing: Sodium chloride; sodium bicarbonate | Concentrated hemodialysis solution | 3004.90.91 |
| 341 | Finished pharmaceutical product containing: Vitamin B1; B2; B6; B12; nicotinamide; sodium pantothenate; biotin; folic acid | Powder for solution for infusion | 3004.50.29 |
| 342 | Finished drug product containing: Atropine sulfate; Hyoscyamine sulfate; Scopolamine HBr; Phenobarbital | Oral form | 3004.49.70 |
| 343 | Finished pharmaceutical product containing: Dicyclomine HCl; Propoxyphene Napsylate, Acetaminophen | Capsule | 3004. 90. 51 |
| 344 | Finished drug product containing: Antazoline hydrochloride; Tetryzoline hydrochloride | Eye drops | 3004.90.99 |
| 345 | Finished pharmaceutical product containing: Spiramycin; Metronidazole | Film-coated tablet | 3004.20.31 |
| 346 | Finished pharmaceutical product containing: Esdepallethrin; piperonyl butoxide | Topical spray solution | 3004.90.99 |
| 347 | Finished drug product containing: Calcium carbonate; Cholecalciferol; Magnesium sulphate | Film-coated tablet | 3004.50.99 |
| 348 | Finished drug product containing: 2,4 Dichlorobenzyl (Dybenal); Amylmetacresol | Lozenge | 3004.90.59 |
| 349 | Finished drug product containing: 2,4 Dichlorobenzyl (Dybenal); Amylmetacresol, Vitamin C | Lozenge | 3004.50.91 |
| 350 | Finished drug product containing: Ampicillin; Sulbactam | Injection form | 3004.10.19 |
| 351 | Finished pharmaceutical product containing: Vitamin A; B1, B2, B6, B12, D3, E, C, calcium Pantothenate, folic acid, calcium zinc,... | Oral form | 3004.50.21 |
| 352 | Finished drug product containing: Budesonide; Formoterol fumarate dihydrate | Powder for inhalation | 3004.32.90 |
| 353 | Finished pharmaceutical product containing: Metronidazole; Chlorhexidine | Gel bôi răng | 3004.20.99 |
| 354 | Finished pharmaceutical product containing: Tenofovir Disoproxil Fumarate; Lamivudine | Oral form | 3004.90.82 |
| 355 | Finished pharmaceutical product containing: Polymethylene Glycol 400; propylene Glycol | Eye drops | 3004.90.99 |
| 356 | Finished pharmaceutical product containing: Menthol; Methyl salicylate; Camphor; Thymol | Plaster | 3005.10.10 |
| 357 | Finished pharmaceutical product containing: Oxycodone HCl; Naloxone HCl | Oral form | 3004.49.11 |
| 358 | Finished pharmaceutical product containing: Meglumine ioxitalamate; Sodium ioxitalamate | Injection form | 3004.90.99 |
| 359 | Finished pharmaceutical product containing: Hydroxypropyl methylcellulose 2910; Dextran 70 | Eye drops | 3004.90.99 |
| 360 | Finished pharmaceutical product containing: Tenofovir disoproxil fumarate; Lamivudine; Efavirenz | Oral form | 3004.90.82 |
| 361 | Finished pharmaceutical product containing: Terbutaline Sulphate; Ambroxol hydrochloride; Guaifenesin; Levomenthol | Oral form | 3004.90.99 |
| 362 | Finished pharmaceutical product containing: Ticarcillin disodium; Clavulanate potassium | Injection form | 3004.10.19 |
| 363 | Finished pharmaceutical product containing: Ticarcillin; Clavulanic acid | Injection form | 3004.10.19 |
| 364 | Finished pharmaceutical product containing: Terbutaline Sulfate; Glyceryl guaiacolate | Oral form | 3004.90.99 |
| 365 | Finished pharmaceutical product containing: Oyster Shell Powder; Dry Cholecalciferol | Oral form | 3004.50.99 |
| 366 | Finished pharmaceutical product containing: Terbutaline Sulphate 1,5mg; Guaiphenesine 50mg; | Oral form | 3004.90.99 |
| 367 | Finished pharmaceutical product containing: Iron Gluconate; Manganese Gluconate; Copper Gluconate | Oral solution | 3004.90.99 |
| 368 | Finished pharmaceutical product containing: Precipitated Calcium carbonate; Cholecalciferol | Oral form | 3004.50.99 |
| 369 | Finished pharmaceutical product containing: Sodium Lactate; Potassium Chloride; Calcium Chloride | Infusion form | 3004.90.99 |
| 370 | Finished pharmaceutical product containing: Tegafur; Gimeracil; Oteracil potassium | Oral form | 3004.90.89 |
| 371 | Finished pharmaceutical product containing: Terbutaline Sulphate; Bromhexine hydrochloride; Guaifenesin; Menthol | Syrup | 3004.90.99 |
| 372 | Finished drug product containing: Silver sulphadiazine; Chlorhexidine gluconate solution | Ointment for external use on the skin | 3004.90.30 |
| 373 | Finished drug product containing: Salts; Iron chloride; Zinc chloride; Manganese chloride; Copper chloride; Chromium chloride; Sodium selenite; Potassium iodide;... | Infusion form | 3004.90.99 |
| 374 | Finished pharmaceutical product containing: Linagliptin; Metformin hydrochloride | Oral form | 3004.90.89 |
| 375 | Finished pharmaceutical product containing: Dried aluminium hydroxide gel Magnesium hydroxide bled; Oxethazaine | Oral form | 3004.90.99 |
| 376 | Finished pharmaceutical product containing: Neomycin; Dexamethasone | Eye drops | 3004.10.20 |
| 377 | Finished pharmaceutical product containing: Losartan; Amlodipine | All forms | 3004.90.89 |
| 378 | Finished pharmaceutical product containing: Efavirenz; Emtricitabine; Tenofovir disoproxil fumarate | Film-coated tablet | 3004.90.82 |
| 379 | Finished pharmaceutical product containing: EPA (Eicosapentaenoic acid); DHA (Docosahexaenoic Acid); Vitamin E | Oral form | 3004.90.82 |
| 380 | Finished pharmaceutical product containing: Indacaterol; Glycopyrronium | Oral form | 3004.90.99 |
| 381 | Finished pharmaceutical product containing: Triamcinolone acetonide; Neomycin Sulphate; Nystatin; Clotrimazole | Skin cream | 3004.10.20 |
| 382 | Finished drug product containing: Colloidal aluminium phosphate; Magnesium oxide | Oral form | 3004.90.99 |
| 383 | Finished pharmaceutical product containing: Sodium amidotrizoate; Meglumine amidotrizoate | Injection form | 3004.90.99 |
| 384 | Finished pharmaceutical product containing: Metronidazole; Clotrimazole; Lactic acid bacillus | Oral form | 3004.20.99 |
| 385 | Finished drug product containing: Crataegus extract; Ginkgo biloba extract; Melissa extract; Garlic oil | Oral form | 3004.90.98 |
| 386 | Finished pharmaceutical product containing: Salbutamol sulphate; Guaiphenesin | Oral form | 3004.90.93 |
| 387 | Finished drug product containing: Clindamycin; Adapalene | Gel | 3004.20.99 |
| 388 | Finished drug product containing: Dextromethorphan HBr; Phenylephrine HCl; Cetirizine HCl; Racementhol | Syrup | 3004. 90. 59 |
| 389 | Finished pharmaceutical product containing: Vitamin B1; B2; B6; Nicotinamide; Sodium Pantothenate | Injection form | 3004.50.91 |
| 390 | Finished pharmaceutical product containing: Vitamin B1; Vitamin B6; | Oral form | 3004.50.21 |
| 391 | Finished drug product containing: Beta-carotene; Dl-alpha-tocopherol acetate; ascorbic acid; Zinc oxide, Cupric oxide; Selenium; Manganese sulfate | Oral form | 3004.50.21 |
| 392 | Finished pharmaceutical product containing: Poly (O-2-hydroxyethyl) starch (HES 130/0,4); Sodium acetate trihydrate; Sodium chloride; Potassium chloride; Magnesium chloride hexahydrate | Infusion form | 3004.90.91 |
| 393 | Finished pharmaceutical product containing: Ezetimibe; Simvastatin | Oral form | 3004.90.99 |
| 394 | Finished pharmaceutical product containing: Levodopa; Carbidopa | Tablet | 3004.90.89 |
| 395 | Finished pharmaceutical product containing: L-Cysteine; Ascorbic acid, Ursodeoxycholic acid, Vitamin E, Ubidecarenone, Thiamine Nitrate, Calcium Pantothenate | Oral form | 3004.50.21 |
| 396 | Finished pharmaceutical product containing: Magnesium Aluminium hydroxide; Magnesium Aluminium silicate; Magnesium oxide; Ranitidine | Oral form | 3004.90.94 |
| 397 | Finished drug product containing: Calcium carbonate; cholecalciferol concentrated powder | Oral form | 3004.50.99 |
| 398 | Finished drug product containing: Ampicillin sodium; Cloxacillin sodium | Injection form | 3004.10.19 |
| 399 | Finished pharmaceutical product containing: Lidocaine; Prilocaine | Topical cream | 3004.90.49 |
| 400 | Finished pharmaceutical product containing: Crataegi extract; Melissa folium extract; Ginkgo biloba leaf extract, Garlic oil | Oral form | 3004.90.98 |
| 401 | Finished pharmaceutical product containing: Magnesium hydroxide, Aluminium hydroxide (as dry gel); Dimethylpolysiloxane | Oral form | 3004.90.99 |
| 402 | Finished pharmaceutical product containing: Methyl salicylate; L-Menthol | Lotion | 3004.90.59 |
| 403 | Finished pharmaceutical product containing: Thiamine nitrate, Riboflavin, Pyridoxine HCl 97% DC, Cyanocobalamin 1% SD, ascorbic acid 97% DC; Calcium pantothenate, nicotinamide | Oral form | 3004.90.55 |
| 404 | Finished drug product containing: Clindamycin phosphate; Clotrimazole; Metronidazole | Vaginal suppository | 3004.20.99 |
| 405 | Finished pharmaceutical product containing: Elbasvir; Grazoprevir | Oral form | 3004.90.89 |
| 406 | Finished pharmaceutical product containing: Miconazole Nitrate; Tinidazole | Vaginal suppository | 3004.20.99 |
| 407 | Finished pharmaceutical product containing: Unithiol; Calcium pantothenate | Oral form | 3004.90.99 |
| 408 | Finished pharmaceutical product containing: Dolutegravir, Lamivudine, tenofovir | Oral form | 3004.90.82 |
| 409 | Finished pharmaceutical product containing: Sofosbuvir; Velpatasvir | Oral form | 3004.90.89 |
| 410 | Finished drug product containing: Brinzolamide; Brimonidine | Eye drops | 3004.90.99 |
| 411 | Finished drug product containing: Atorvastatin, Perindopril, Amlodipine | Oral form | 3004.90.89 |
| 412 | Finished drug product containing: Dapagliflozin; Metformin | Oral form | 3004.90.89 |
| 413 | Finished pharmaceutical product containing: Sacubitril, Valsartan | Oral form | 3004.90.89 |
| 414 | Finished pharmaceutical product containing: umeclidinium, vilanterol | Metered-dose inhalation powder | 3004.90.99 |
| 415 | Finished pharmaceutical product containing: Pravastatin; Fenofibrate | Oral form | 3004.90.89 |
| 416 | Finished pharmaceutical product containing: Ledipasvir; Sofosbuvir | Oral form | 3004.90.99 |
| 417 | Finished pharmaceutical product containing: Netupitant; Palonosetron | Oral form | 3004.90.99 |
| 418 | Finished pharmaceutical product containing: Drospirenone; Ethinyl estradiol | Oral form | 3004.39.00 |
| 419 | Finished pharmaceutical product containing: Metoprolol tartrate; Ivabradine | Oral form | 3004.90.89 |
| 420 | Finished pharmaceutical product containing: Tetrakis (2-methoxy isobutyl isonitrile) copper (I) tetrafluoroborate | Lyophilized powder for injection | 3004.90.99 |
| 421 | Finished pharmaceutical product containing: Sodium molybdate 5-50GBq; Sodium pertechnetate | Elution solution for injection | 3004.90.99 |
| 422 | Finished pharmaceutical product containing: Tiotropium; Olodaterol | Inhalation solution | 3004.90.89 |
| 423 | Finished pharmaceutical product containing: umeclidinium, vilanterol, fluticasone furoate | Metered-dose inhalation powder | 3004.32.90 |
| 424 | Finished drug product containing vilanterol, fluticasone furoate | Metered-dose inhalation powder | 3004.32.90 |
| 425 | Finished pharmaceutical product containing: Dutasteride, Tamsulosin hydrochloride | Hard capsule | 3004.39.00 |
Digitised for reference; formatting may differ slightly from the original — verify against the attached original file or the official gazette. Vietnamese legal text.